Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

84 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

NCT05463263

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Memorial Sloan Kettering New York, United States
  • Hôpital Saint-Louis Paris, France
View all 15 locations
View Trial Details
Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

NCT07188558

Conditions
Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of Arkansas Little Rock, Arkansas, United States
View all 38 locations
View Trial Details
Recruiting

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

NCT06528301

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +19 more
Locations
  • City of Hope Duarte, California, United States
  • The David and Etta Jonas Center for Cellular Therapy Chicago, Illinois, United States
  • Washington University School of Medicine/Siteman Cancer Center St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details

Related conditions